FDA Approves Nausea Prevention Drug

By admin aapc
In Industry News
September 2, 2008
Comments Off on FDA Approves Nausea Prevention Drug

The FDA has approved a new oral formulation of ALOXI(R) (palonosetron hydrochloride) made by Eisai Corporation of North America and its partner Helsinn Healthcare SA for the prevention of chemotherapy-induced nausea and vomiting (CINV) (Medical News Today, Aug. 24).

Author
Recent Posts

admin aapc

FDA Approves Nausea Prevention Drug

Have you used AAPC's member discount savings program (e.g., travel, entertainment)? (On top menu: Resources/Other Resources/Savings Center)

Hot Topics